NEW YORK ( TheStreet) -- Alexion Pharmaceuticals (Nasdaq: ALXN) hit a new 52-week high Tuesday as it is currently trading at $69.39, above its previous 52-week high of $68.50 with 255,841 shares traded as of 10:05 a.m. ET. Average volume has been 1.7 million shares over the past 30 days. Alexion has a market cap of $12 billion and is part of the health care sector and drugs industry. Shares are up 68.5% year to date as of the close of trading on Monday. Alexion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologic therapeutic products in the United States, Europe, Latin America, Japan, and the Asia Pacific. The company has a P/E ratio of 106.9, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7.
- Practice your ALXN trading strategies and win cash in our stock game.